Source: NIH ODS + Ross 2006 review
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Vitamin A (not specified) has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Vitamin A leaves the liver bound to retinol-binding protein, and making that protein depends on adequate zinc. Zinc also serves as the cofactor for the dehydrogenase that oxidises retinol to retinal. Where zinc status is poor, liver vitamin A stores can be adequate while circulating retinol stays low, and correcting the vitamin A alone does not resolve it.
Retinoids influence the release of iron from hepatic and splenic stores and support erythroid precursor development. In populations where both nutrients are short, adding vitamin A raises haemoglobin beyond what iron alone achieves. This applies to correcting a shortfall, not to adding either nutrient on top of an already adequate intake.
Retinol has a conjugated polyene chain that is vulnerable to oxidation both in the capsule and in circulating lipoproteins. Tocopherol intercepts the lipid peroxyl radicals that would otherwise degrade it. This is why oil-based retinyl ester products almost always carry added tocopherol, and it is a stability relationship as much as a physiological one.
The vitamin D receptor cannot bind its response elements without pairing with retinoid X receptor, and retinoic acid receptors use the same partner. At high retinoid exposure, RXR availability becomes a point of competition and vitamin D signalling can be dampened. At ordinary intakes the two nutrients are complementary and are co-formulated as a matter of course, and the competition is a high-dose phenomenon.
Beta-carotene is the plant-derived route to vitamin A, converted in the intestinal wall at a rate that is feedback-regulated by vitamin A status. That regulation is the reason provitamin A carotenoids do not accumulate to toxic levels the way preformed retinol can. Conversion efficiency also varies substantially between people because of common BCO1 genetic variants, so a carotenoid dose does not translate to a fixed retinol equivalent.
Retinyl esters need pancreatic and intestinal esterases plus bile salt micelles to be absorbed. Taken on an empty stomach with no fat, absorption falls. A lipid vehicle in the capsule or a meal containing fat is what makes the dose count.
Anyone with reduced bile output, whether from gallbladder removal or cholestasis, absorbs fat-soluble vitamins poorly. Supplemental bile acids restore some micelle formation. This is relevant to a specific group rather than to general use, and it is a rationale grounded in physiology rather than in trials of the pairing.
Vitamins A, D, E and K all cross the enterocyte through overlapping micellar and transporter-mediated routes. At ordinary supplemental amounts they are co-formulated without apparent problem. At the high end, competition for the shared pathway has been shown for several of these pairs, which is an argument for spacing large single-nutrient doses rather than for avoiding combination products.
High doses of one carotenoid reduce the absorption of others because they compete for space in the same mixed micelles and for the same intestinal transporters. This is well characterised between beta-carotene and lutein. Single-carotenoid megadosing is where it matters; mixed-carotenoid formulations at food-like ratios are less affected.
Ascorbate regenerates the tocopheroxyl radical back to tocopherol at the lipid-water interface, and tocopherol is what shields retinol from oxidation in lipoproteins. The chain is established chemistry, but the practical consequence for retinol status at ordinary intakes has not been quantified. Read it as mechanistic.
Cod liver oil and similar fish liver oils contain preformed retinol as part of the natural matrix, which is a point buyers often miss when stacking a separate vitamin A capsule on top. A long-chain triglyceride vehicle also improves absorption of added retinyl esters. Anyone combining the two should count the vitamin A already present in the oil against the total.
Astaxanthin competes for the same absorption machinery as other carotenoids without contributing any retinol. Taking it alongside a provitamin A carotenoid can lower how much of the latter is absorbed. With preformed retinyl esters the competition is smaller, since ester hydrolysis and re-esterification follow a partly separate route.
Nothing specific on file for Vitamin A (not specified). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.